seed
Stage
1
Investors
About
Particella develops an oral lipid nanoparticle technology to deliver nucleic acids, such as mRNA, for therapeutic applications.
Explore Particella's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.